Literature DB >> 7678192

Three antigenic variant groups in human respiratory syncytial virus subgroup B isolated in Japan.

K Nagai1, H Tsutsumi, H Yamazaki, S Pattamadilok, S Chiba.   

Abstract

Nineteen hybridomas producing monoclonal antibodies (MAbs) against the structural proteins of strain 58-17, a subgroup B field strain of respiratory syncytial virus (RSV) isolated in Japan, were obtained by fusion of X63 myeloma cells with spleen cells from BALB/c mice immunized with the virus-infected HEp-2 cells. Seven clones were found to produce antibodies against the fusion protein (F), five against the large glycoprotein (G), five against the nucleoprotein (NP) and two against the 22k protein by radioimmunoprecipitation assay. By competitive binding assay with the MAbs, at least seven, two, three and one epitopes were defined on the F, G, NP and 22k protein components of subgroup B strain, respectively. Of these epitopes, three, two and one epitopes on the F, G and NP components were different from subgroup A strain, respectively. Fifty-three other field strains of subgroup B isolated in Sapporo, Japan, during nine epidemic years from 1980 to 1989, were examined for reactivity with the MAbs by ELISA. Different reactivity to one anti-NP antibody suggested that the 53 strains can be divided into three groups (B-a: 26 strains, B-b: 26 strains, and one other strain). The dominant strain prevailing during the 1984 to 1988 epidemic years had changed from B-a to B-b. All of the 53 subgroup B strains reacted similarly with the other 18 MAbs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678192     DOI: 10.1007/bf01309788

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization.

Authors:  R CHANOCK; B ROIZMAN; R MYERS
Journal:  Am J Hyg       Date:  1957-11

2.  Two distinct subtypes of human respiratory syncytial virus.

Authors:  M A Mufson; C Orvell; B Rafnar; E Norrby
Journal:  J Gen Virol       Date:  1985-10       Impact factor: 3.891

3.  Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.

Authors:  C Orvell; E Norrby; M A Mufson
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

4.  Antigenic variation of human RSV strains isolated in Japan.

Authors:  H Tsutsumi; K Nagai; K Suga; Y Chiba; S Chiba; S Tsugawa; P L Ogra
Journal:  J Med Virol       Date:  1989-02       Impact factor: 2.327

5.  Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites.

Authors:  H Tsutsumi; T D Flanagan; P L Ogra
Journal:  J Gen Virol       Date:  1987-08       Impact factor: 3.891

6.  Monoclonal antibodies to human respiratory syncytial virus and their use in comparison of different virus isolates.

Authors:  H B Gimenez; P Cash; W T Melvin
Journal:  J Gen Virol       Date:  1984-05       Impact factor: 3.891

7.  Structural differences between subtype A and B strains of respiratory syncytial virus.

Authors:  E Norrby; M A Mufson; H Sheshberadaran
Journal:  J Gen Virol       Date:  1986-12       Impact factor: 3.891

8.  Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks.

Authors:  R M Hendry; A L Talis; E Godfrey; L J Anderson; B F Fernie; K McIntosh
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

9.  Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

Authors:  C R Bangham; P J Openshaw; L A Ball; A M King; G W Wertz; B A Askonas
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

10.  Antigenic and structural variation in the major nucleocapsid protein of respiratory syncytial virus.

Authors:  K A Ward; J S Everson; P R Lambden; P J Watt
Journal:  J Gen Virol       Date:  1984-10       Impact factor: 3.891

View more
  5 in total

Review 1.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Identification of a variant subgroup A strain of respiratory syncytial virus.

Authors:  M A Mufson; R J Stanek
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  Respiratory syncytial virus subgroup B dominance during one winter season between 1987 and 1992 in Vancouver, Canada.

Authors:  E Thomas; M J Margach; C Orvell; B Morrison; E Wilson
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

4.  Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection.

Authors:  H Yamazaki; H Tsutsumi; K Matsuda; K Nagai; P L Ogra; S Chiba
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

5.  Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus.

Authors:  K Matsuda; H Tsutsumi; Y Okamoto; C Chiba
Journal:  Clin Diagn Lab Immunol       Date:  1995-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.